South Korea-based DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting the latter exclusive rights ...

Single-cell RNA sequencing then identifies the sequences of antibodies that cause these diseases. “Next, we re-engineer IgE antibodies into IgG antibodies that can protect from, rather than ...

Antibody Solutions, a leading provider of fit-for-purpose antibody discovery services, announced today that for the first ...

The global antibody discovery market size is anticipated to reach approximately USD 22,570 million by 2034, up from USD 9,570 ...

“Integrated with single cell sequencing technology, the target antibody sequences can be easily obtained. This reduces the cycle of the whole process, from defining the target to generating ...

The sequence homology is over 95%; PTM and aggregation prediction reports are also available 100% success rate As quick as 3–4 weeks to offer required humanized antibodies Affinity evaluated by ...

In the landmark Amgen v. Sanofi case (previously covered here), the Supreme Court affirmed that patent claims drawn to a genus of ...

The researchers created input data for the deep-learning model using sequences of known antigen binders. This method correctly predicted 90% of the best antibodies in one test with 1,000 ...

The resulting antibodies are maximally de-risked with respect to immunogenicity, because every V region sequence has been expressed in a human body before. This, in combination with the early de ...

Monoclonal antibodies are considered the most rapidly growing class of therapeutics. Critical quality attributes such as sequence assessment, charge and size variants must be thoroughly monitored ...